On June 27, 2025, Jaguar Health, Inc. finalized exchange agreements to issue 170 shares of Series M Preferred Stock to Iliad in exchange for a $4.25 million reduction of a previous royalty interest and 90 shares of Series M Preferred Stock to Streeterville for a $2.25 million reduction of another royalty interest.